HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a double-edged sword in human cancer. While indispensable for embryonic patterning ...

The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...

As the landscape of cancer treatment evolves, fusion genes stand at the forefront of precision medicine, offering new hope for patients. With continuous advancements in genomic research and targeted ...